CoChat

Follistatins in glucose regulation in healthy and obese individuals

Open access
Perakakis, Nikolaos, Kokkinos, Alexander, Peradze, Natia, Tentolouris, Nicholas, Ghaly, Wael, Tsilingiris, Dimitrios, Alexandrou, Andreas, Mantzoros, Christos S. · 2019 · Diabetes, Obesity and Metabolism
Cited by 56

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Aims: It has been suggested recently that follistatin (FST) and its homologous protein, follistatin‐like 3 (FSTL3), may be a therapeutic target in the treatment of type 2 diabetes because of their glucose‐regulatory effects in rodents. Materials and Methods: We investigated this hypothesis in humans by studying the physiology of a possible glycaemia–follistatin feedback loop, that is, whether glucose, but not lipid intake (oral or intravenous), can regulate circulating FST and FSTL3 in healthy humans (n = 32), whether the levels of follistatins change in response to various types of bariatric operation in morbidly obese individuals, with or without type 2 diabetes (n = 41), and whether such changes are associated prospectively with improvement of glucose homeostasis/insulin sensitivity. Results: In healthy individuals, circulating FST decreases after intravenous or oral glucose intake compared to controls, indicating the presence of a negative feedback mechanism. In morbid obesity, insulin resistance, glycaemia, circulating FST and FSTL3 are all reduced (by 22%‐33%) after Roux‐en‐Y gastric bypass (RYGB) and sleeve gastrectomy. Importantly, the changes in circulating FST 3 months after bariatric surgery are associated prospectively with the changes in glucose, insulin, HOMA‐IR and HbA1c observed 6 months postoperatively in individuals with and without type 2 diabetes. Conclusions: Our findings provide evidence of an important role of FST in glucose homeostasis in healthy individuals as well as in severely obese individuals with insulin resistance and type 2 diabetes. Our data extend recent results from animal studies to humans and support the need for further evaluation of FST inactivation strategies for targeting hyperglycaemia and insulin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.13572

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 12

  1. 10.1210/jc.2011-1453 · DOI
  2. 10.1016/j.metabol.2018.05.003 · DOI · Paper page
  3. 10.1210/jc.2011-1665 · DOI · Paper page
  4. 10.1016/j.metabol.2016.07.009 · DOI · Paper page
  5. 10.1210/er.2014-1003 · DOI · Paper page
  6. 10.1016/j.metabol.2014.10.007 · DOI
  7. 10.1073/pnas.0607966104 · DOI · Paper page
  8. 10.1590/1414-431X20143869 · DOI
  9. 10.1210/en.2012-1844 · DOI
  10. 10.1210/jc.2015-4141 · DOI
  11. 10.1001/jamasurg.2014.2440 · DOI · Paper page
  12. 10.1016/j.soard.2018.03.003 · DOI · Paper page

Cited by

See all 56

Metadata

Authors
Perakakis, N., Kokkinos, A., Peradze, N., Tentolouris, N., Ghaly, W., Tsilingiris, D., Alexandrou, A., & Mantzoros, C. S.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2018-12-03
Volume
21
Issue
3
Pages
683-690
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2900161728
Cited by
56
References
11
FWCI
4.95
Type
journal article
Language
en
Open access
green
Funders
  • Deutsche Forschungsgemeinschaft (389891681, 389891681 (PE 2431/2‐1))
  • National Institutes of Health (K24DK081913)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.